Glaxosmithkline | GSK - Creditori Commerciali

Prezzo Delle Azioni
51.69
Cambio Giornaliero
-7.43 -12.57%
Mensile
-12.77%
Annuale
29.71%
Q2 Previsione
53.52




Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bausch Health Companies USD 600M 16M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 40.44M 6M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
J&J USD 10.46B 1.53B 2026-03
Merck USD 4.15B 102M 2025-09
Novartis USD 4.46B 99M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Zoetis USD 487M 77M 2025-12